Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Fair

Showing results (281-290 of 290) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 290 results.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.
Progress in Clinical and Biological Research|January 1, 1988
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
Cancer Research|December 15, 1994
Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assaysR S Israeli, W H Miller, S L Su, et al.
Urology|August 15, 2001
Overview consensus statementP R Carroll, W R Fair, G D Grossfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerM J Zelefsky, S A Leibel, P B Gaudin, et al.
Ultrasonic Imaging|April 18, 2002
Spectrum-analysis and neural networks for imaging to detect and treat prostate cancerE J Feleppa, R D Ennis, P B Schiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Urology|March 1, 1997
Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reactionS L Su, W D Heston, M Perrotti, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Biochimica Et Biophysica Acta|December 5, 1998
Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen geneD S O'Keefe, S L Su, D J Bacich, et al.
Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.
Progress in Clinical and Biological Research|January 1, 1988
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
Cancer Research|December 15, 1994
Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assaysR S Israeli, W H Miller, S L Su, et al.
Urology|August 15, 2001
Overview consensus statementP R Carroll, W R Fair, G D Grossfeld, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerM J Zelefsky, S A Leibel, P B Gaudin, et al.
Ultrasonic Imaging|April 18, 2002
Spectrum-analysis and neural networks for imaging to detect and treat prostate cancerE J Feleppa, R D Ennis, P B Schiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Urology|March 1, 1997
Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reactionS L Su, W D Heston, M Perrotti, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Biochimica Et Biophysica Acta|December 5, 1998
Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen geneD S O'Keefe, S L Su, D J Bacich, et al.
Pageof 29